Publications

Detailed Information

Fluctuation of Peripheral Blood T, B, and NK Cells during a Menstrual Cycle of Normal Healthy Women

DC Field Value Language
dc.contributor.authorLee, Sungki-
dc.contributor.authorKim, Jeeyun-
dc.contributor.authorJang, Byungwoo-
dc.contributor.authorHur, Sungeun-
dc.contributor.authorKil, Kihyun-
dc.contributor.authorLee, Millina-
dc.contributor.authorFukui, Atsushi-
dc.contributor.authorKwak-Kim, Joanne Y.-
dc.contributor.authorGilman-Sachs, Alice-
dc.contributor.authorChoi, Youngmin-
dc.contributor.authorNa, Baegju-
dc.contributor.authorJung, Unsuk-
dc.date.accessioned2012-06-04T08:43:02Z-
dc.date.available2012-06-04T08:43:02Z-
dc.date.issued2010-07-01-
dc.identifier.citationJOURNAL OF IMMUNOLOGY; Vol.185 1; 756-762ko_KR
dc.identifier.issn0022-1767-
dc.identifier.urihttps://hdl.handle.net/10371/76807-
dc.description.abstractCyclical hormonal changes during an ovarian cycle may affect immune responses, which is crucial for the embryonic implantation. We aim to investigate whether the levels and activity of T, B, and NK cells change during a menstrual cycle. Twenty-two normally cycling women were enrolled and peripheral blood was drawn serially during a menstrual cycle. Intracellular cytokine expression of CD3(+) CD4(+) and CD3(+) CD8(+) cells, and Th1/Th2 cytokine-producing T cell ratios were determined using flow cytometric analysis. NK cell cytotoxicity was measured by flow cytometric analysis at E: T ratios of 50:1, 25:1, and 12.5:1 and also using LU at 20%. Proportions (percentage) of CD3(+) (p = 0.046) and CD3(+) CD4(+) (p = 0.002) T cells were increased in the follicular phase compared with the luteal phase. The levels of CD3(-)CD56(+) (p = 0.010) and CD3(-)CD56(dim) (p = 0.012) NK cells and NK cytotoxicity at E:T ratio of 50:1, 25:1, and 12.5:1 and LU at 20% were significantly increased in the luteal phase compared with the follicular phase. Even though IL-10-producing CD3(+) CD4(+) T cells were significantly lower in the midluteal phase as compared with the early follicular phase, proportions of CD19(+) B cells, CD3(+) CD56(+) NKT cells, Th1 cytokine-producing T cell subsets, and ratios of Th1/Th2 cytokine-producing T cells were not significantly changed during a menstrual cycle. We conclude that peripheral blood NK and T cell levels as well as NK cytotoxicity are changed during a menstrual cycle. Neuroendocrine regulation on immune responses is suggested during an ovarian cycle, which may be critical for embryonic implantation and pregnancy. The Journal of Immunology, 2010, 185: 756-762.ko_KR
dc.language.isoenko_KR
dc.publisherAMER ASSOC IMMUNOLOGISTSko_KR
dc.titleFluctuation of Peripheral Blood T, B, and NK Cells during a Menstrual Cycle of Normal Healthy Womenko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor이성기-
dc.contributor.AlternativeAuthor김지윤-
dc.contributor.AlternativeAuthor장병우-
dc.contributor.AlternativeAuthor허성은-
dc.contributor.AlternativeAuthor정운석-
dc.contributor.AlternativeAuthor길기현-
dc.contributor.AlternativeAuthor나백주-
dc.contributor.AlternativeAuthor이밀리나-
dc.contributor.AlternativeAuthor최영민-
dc.identifier.doi10.4049/jimmunol.0904192-
dc.citation.journaltitleJOURNAL OF IMMUNOLOGY-
dc.description.citedreferenceArruvito L, 2008, J IMMUNOL, V180, P5746-
dc.description.citedreferenceKalu E, 2008, AM J REPROD IMMUNOL, V59, P206, DOI 10.1111/j.1600-0897.2007.00565.x-
dc.description.citedreferenceDosiou C, 2008, J ENDOCRINOL, V196, P67, DOI 10.1677/JOE-07-0317-
dc.description.citedreferenceKitaya K, 2007, J REPROD IMMUNOL, V76, P45, DOI 10.1016/j.jri.2007.03.010-
dc.description.citedreferenceKeskin DB, 2007, P NATL ACAD SCI USA, V104, P3378, DOI 10.1073/pnas.061198104-
dc.description.citedreferenceJones RL, 2006, REPRODUCTION, V132, P217, DOI 10.1530/rep.1.01076-
dc.description.citedreferenceIzumi Y, 2006, J LAB CLIN MED, V147, P242, DOI 10.1016/j.lab.2006.01.001-
dc.description.citedreferenceMo R, 2005, J IMMUNOL, V174, P6023-
dc.description.citedreferencePhiel KL, 2005, IMMUNOL LETT, V97, P107, DOI 10.1016/j.imlet.2004.10.007-
dc.description.citedreferenceDosiou C, 2005, ENDOCR REV, V26, P44, DOI 10.1210/er.2003-0021-
dc.description.citedreferencevan den Heuvel MJ, 2005, IMMUNOL INVEST, V34, P273, DOI 10.1081/IMM-200064488-
dc.description.citedreferenceKumru S, 2004, J REPROD IMMUNOL, V63, P31, DOI 10.1016/j.jri.2004.02.001-
dc.description.citedreferencevan Nieuwenhoven ALV, 2003, HUM REPROD UPDATE, V9, P347, DOI 10.1093/humupd/dmg026-
dc.description.citedreferenceCooper GS, 2003, AUTOIMMUN REV, V2, P119-
dc.description.citedreferenceKwak-Kim JYH, 2003, HUM REPROD, V18, P767, DOI 10.1093/humrep/deg156-
dc.description.citedreferenceTanriverdi F, 2003, J ENDOCRINOL, V176, P293, DOI 10.1677/joe.0.1760293-
dc.description.citedreferenceGrimaldi CM, 2002, J CLIN INVEST, V109, P1625, DOI 10.1172/JCI200214873-
dc.description.citedreferenceMiyaura H, 2002, J IMMUNOL, V168, P1087-
dc.description.citedreferenceCurran EM, 2001, CELL IMMUNOL, V214, P12, DOI 10.1006/cimm.2002.1886-
dc.description.citedreferenceWhitacre CC, 2001, NAT IMMUNOL, V2, P777-
dc.description.citedreferenceRogers A, 2001, BONE, V29, P30-
dc.description.citedreferenceMcMurray RW, 2001, CYTOKINE, V14, P324, DOI 10.1006/cyto.2001.0900-
dc.description.citedreferenceYovel G, 2001, GYNECOL ONCOL, V81, P254, DOI 10.1006/gyno.2001.6153-
dc.description.citedreferenceSouza SS, 2001, J REPROD IMMUNOL, V50, P151-
dc.description.citedreferenceKeller ET, 2001, J REPROD IMMUNOL, V50, P41-
dc.description.citedreferenceBouman A, 2001, AM J REPROD IMMUNOL, V45, P130-
dc.description.citedreferenceBen-Eliyahu S, 2000, BRIT J CANCER, V83, P1747-
dc.description.citedreferenceFaas M, 2000, FERTIL STERIL, V74, P1008-
dc.description.citedreferenceWhitacre CC, 1999, SCIENCE, V283, P1277-
dc.description.citedreferenceGilman-Sachs A, 1999, AM J REPROD IMMUNOL, V41, P99-
dc.description.citedreferenceCHEN L, 1999, PITUITARY, V2, P191-
dc.description.citedreferenceEhring GR, 1998, J EXP MED, V188, P1593-
dc.description.citedreferenceKwak JYH, 1998, AM J REPROD IMMUNOL, V40, P352-
dc.description.citedreferenceBeer AE, 1996, AM J REPROD IMMUNOL, V35, P376-
dc.description.citedreferenceRuiz JE, 1996, AM J REPROD IMMUNOL, V35, P370-
dc.description.citedreferenceKWAK JYH, 1995, AM J REPROD IMMUNOL, V34, P93-
dc.description.citedreferenceNORTHERN ALD, 1994, P SOC EXP BIOL MED, V207, P81-
dc.description.citedreferenceGIGLIO T, 1994, LIFE SCI, V54, P1305-
dc.description.citedreferenceLOPEZKARPOVITCHS X, 1993, REV INVEST CLIN, V45, P247-
dc.description.citedreferenceSZEKERESBARTHO J, 1990, CELL IMMUNOL, V125, P273-
dc.description.citedreferenceGROSSMAN CJ, 1985, SCIENCE, V227, P257-
dc.description.citedreferenceSULKE AN, 1985, BRIT MED J, V290, P884-
dc.description.citedreferenceCOULAM CB, 1983, AM J REPROD IMMUNOL, V4, P88-
dc.description.tc5-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share